Pharmacotherapy for Smoking Cessation in Cardiovascular Patients

Sun-Hee Kim, Hong-Jun Cho
2015 Journal of the Korean Society for Research on Nicotine and Tobacco  
Smoking is the leading cause of recurrence and readmission for patients with cardiovascular diseases. Pharmacotherapy is the most powerful method to increase the cessation rate especially when combined with medical counseling, however, most drugs used for smoking cessation have potential cardiovascular side effects. Thus it is important question whether drugs for pharmacotherapy for smokers with cardiovascular diseases is effective and safe. In this article, we reviewed the effectiveness and
more » ... ety of smoking cessation drugs including nicotine replacement therapy, bupropion, and varenicline for cardiovascular patients. In general, all drugs seemed to be effective for smoking cessation and there was no clear evidence that these medications increase major cardiovascular side effects for patients with cardiovascular disease. Because there are also limitations such as sample size and study design, we should be careful to interpret these.
doi:10.25055/jksrnt.2015.6.2.71 fatcat:c3pq5ptlujb5totqwbbuwitgbi